IHS Chemical Week

Regions :: China

Orchid exits API jv in China

5:41 AM MST | November 12, 2012 | Deepti Ramesh

Orchid Chemicals & Pharmaceuticals (Chennai, India), a leading Indian pharmaceutical company, says it is exiting its 50-50 active pharmaceutical ingredient (API) manufacturing joint venture in China with North China Pharmaceutical Corp. (NCPC; Shijiazhuang, China), NCPC-Orchid Pharmaceuticals (Shijiazhuang). Orchid’s 50% stake in the jv will be transferred to NCPC for a total cash consideration of $13.9 million, Orchid says. Orchid and NCPC formed the jv in 2002 to establish a cephalosporin API manufacturing facility at Shijiazhuang. “With...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa